MazdutideMDT5

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Mazdutide

Weight reduction and weight management

Mazdutide specifications and reference prices. Select a specification to add it to your cart.

5mg/vial x 10vials
Reference priceUS$333.33

For laboratory research only. Not for human or veterinary use.

COA 检测报告 / Reports

Compare all specifications & reference prices
SKUSpecification / packReference price (USD)
MDT55mg/vial x 10vialsUS$333.33
MDT1010mg/vial x 10vialsUS$612.12

Temporarily sold-out specifications can still be added to an inquiry to ask about restocking. An inquiry is not an order or an agreed price.

RESEARCH FOCUS

Main Uses & FAQs

This page organizes directly relevant information on Mazdutide regarding weight loss and weight management. First, look at the research questions and findings, then verify the population or species, study preparations, and scope of interpretation.

Main TopicsWeight Loss · Weight Management
USAGE REFERENCE

Mazdutide · Usage reference (for research purposes)

The following presents common research-context references for reconstitution, storage, dosage and cycles. The following presents common references in research settings. This page does not constitute advice for use in humans or animals.

🧪Reconstitution

Suggested Diluent
Bacteriostatic Water (containing 0.9% benzyl alcohol); some peptides may use sterile water or acetic acid to aid dissolution. See the individual product descriptions.
Diluent Volume
Slowly introduce the diluent along the vial wall until the lyophilized powder is covered. A common example is 5 mg reconstituted with 2 mL of bacteriostatic water, yielding approximately 2.5 mg/mL. Referenced reconstitution volumes are approximately 1–2.5 mL, with 2 mL commonly used. It is suggested to select and record a fixed volume based on the COA supplied with the purchase.
Handling Notes
Introduce the diluent slowly along the vial wall rather than directly onto the lyophilized powder. Leave it for 60–90 seconds to dissolve naturally; do not shake vigorously.

💾Storage

Unreconstituted Lyophilized Powder
Refrigerate at 2–8°C, protected from light; avoid repeated freeze–thaw cycles.
After Reconstitution
Refrigerate at 2–8°C; a common recommendation is touse within 28 days; do not freeze.
Transport
For short periods, use insulated packaging with ice packs; avoid high temperatures and direct light.

📏Dosage Reference (Research)

Purpose / SettingCommon Reference
Administration RouteSubcutaneous injection
FrequencyOnce weekly

🔁Cycle

Subcutaneous injection once per week.

View the Complete Usage Guide Library →

Note: The above describes common research-context references, rather than clinical recommendations. Refer to the batch COA and research protocol. For research use only; not for human or animal use.

Research SummaryKey Findings

What research findings exist for Mazdutide in weight loss and weight management?

Significant weight loss in all dose groups at 32 weeks compared with placebo. Another study reported: at 60 weeks, the 9mg group had an average weight change of about -16.65%, placebo about -1.50%.[1] ↗ [2] ↗

Before ReadingStudy populations, species, formulations and delivery conditions each have a defined scope. Research on an ingredient does not establish that this site's product batches have been validated for efficacy in humans or veterinary use.
3 Main ReferencesSorted by First Publication Date ↓
Human Study2026REF. 01

What were the findings of Mazdutide dose exploration in the U.S. population?

Research Findings

Significant weight loss in all dose groups at 32 weeks compared with placebo.[1] ↗

Study Design

United States, 179 adults, randomized Phase II trial

Scope & Limitations

Dose exploration and specific trial formulations.

View the Article Title and Full Citation+

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

Hsia SH, Bays HE, Billings LK, Weideman AMK, Mather KJ, Coskun T, Haupt A, Thomas MK, Tham LS, Calderon B, Ni W, De Araujo OFG.

The Lancet. Diabetes & Endocrinology · Volume and issue year 2026
First published 2026-08-21 · PMID 42628555
DOI 10.1016/s2213-8587(26)00160-9

Human Study2026REF. 02

What did the long-term weight study of GLORY-2 observe?

Research Findings

At week 60, the 9mg group had an average weight change of about -16.65%, placebo about -1.50%.[2] ↗

Study Design

461 obese adults in China; GLORY-2 randomized trial.

Scope & Limitations

Population and follow-up restrictions; Does not represent the website's 5mg bottle usage.

View the Article Title and Full Citation+

Treatment With 9-mg Mazdutide for Weight Reduction in Chinese Adults With Obesity: The GLORY-2 Randomized Clinical Trial.

Gao L, Jiang H, Cai H, Tian J, Shi B, Qiu W, Huang C, Han J, Zhang S, Pang S, Bi Y, Chen L, Gu X, Han J, Ma Q, Deng H, Wang Y, Li L, Han-Zhang H, Qian L, Ji L, GLORY-2 Trial Investigators.

JAMA · Volume/Issue/Year 2026
First published 2026-08-01 · PMID 42251595
DOI 10.1001/jama.2026.8142

Human Study2026REF. 03

What were the findings of the early dose trial in obese adults in China?

Research Findings

24-week 9mg group weight loss about 12.78%, better than placebo.[3] ↗

Study Design

China, 80 adults with BMI ≥30 and no diabetes, randomized Phase II

Scope & Limitations

Small-sample trial, cannot generalize to all weight populations.

View the Article Title and Full Citation+

Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m<sup>2</sup> but without diabetes: A phase 2 randomized controlled trial.

Ji L, Jiang H, Cheng Z, Li X, Pang S, Zhang Y, Qiu W, Ma Q, Liu Z, Wang Y, Deng H, Du H, Han-Zhang H, Qian L.

Med (New York, N.Y.) · Volume/Issue Year 2026
First published 2026-03-23 · PMID 41875890
DOI 10.1016/j.medj.2026.101063

i

Currently, 3 original studies related to the theme of this page have been selected. The number of studies includes different designs, populations, or preparations, not commercial clinical efficacy ratings. This page is a usage-oriented positive data selection, not a systematic review or dosing recommendation. Historical studies, combination preparations, and special models are all separately indicated.

GO DEEPER

What Questions Do These Studies Address?

Compare study populations, findings and scope.

↗
QUESTIONS, ANSWERED

Mazdutide · Frequently Asked Questions.

What research findings exist for Mazdutide in weight loss and weight management?+

Significant weight loss in all dose groups at 32 weeks compared with placebo. Another study reported: at 60 weeks, the 9mg group had an average weight change of about -16.65%, placebo about -1.50%.[1] ↗ [2] ↗

Can the dosage used in Mazdutide weight loss trials be directly applied to bottled specifications?+

Not possible. Escalation schemes, follow-ups, and trial formulations in human trials are complete conditions; the total amount in a single bottle does not equal a single dose, nor can it predict the degree of individual weight loss.[1] ↗ [2] ↗ [3] ↗

Mazdutide—these conclusions apply to which study populations?+

United States, 179 adults, randomized Phase II trial; China, 461 obese adults; GLORY-2 randomized trial; China, 80 adults with BMI≥30 without diabetes, randomized Phase II trial. Dose exploration and specific trial formulations.[1] ↗ [2] ↗ [3] ↗

VENTRO PEPTIDES & BIOTECH · RESEARCH PRODUCT RETAIL

Research peptides. Shop by product.

Compare specifications, reference prices and COA reports. Add products to your cart to request a quote.

Ventro Peptides & Biotech Logo
QUALITY DOCUMENTSCOA BY PRODUCTGLOBAL DELIVERYTECHNICAL SUPPORT

01 / CATALOG

Browse products

7 products Product names, specifications, and prices follow the current quotation
SemaglutideSM10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Semaglutide

10mg/vial x 10vials

US$90.91
TirzepatideTR20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Tirzepatide

20mg/vial x 10vials

US$160.61
RetatrutideRT10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Retatrutide

10mg/vial x 10vials

US$109.09
BPC157BC10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Repair & Recovery Research

BPC157

10mg/vial x 10vials

US$133.33
MOTS-CMS20COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Longevity & Mitochondrial Research

MOTS-C

20mg/vial x 10vials

US$257.58
LiraglutideLR10COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

GLP-1 & Metabolic Research

Liraglutide

10mg*10vials

US$164.71
IGF-lr3IG1COA

Images are illustrative. Actual specifications are as selected and confirmed in writing.

Growth Hormone & IGF-1

IGF-lr3

1mg/vial x 10vials

US$505.88

03 / ABOUT VENTRO

Reliable peptide supply, built for long-term partnerships.

Ventro supports research product retail purchases with clear pack specifications, available quality documents, and responsive international support.

  • High-purity peptides
  • Available COA reports
  • COA & quality documentation
  • Flexible small-quantity purchases
  • Reliable global fulfillment
  • Research product retail support

04 / QUALITY SYSTEM

Quality without compromise

Browse the available COA reports by product. Confirm documentation for your order with our team.

Controlled quality workflowRaw material to final release
Responsive global supportProduct matching and technical support

RESEARCH PRODUCT INQUIRY

Submit a product inquiry

Tell us the product, specification, and expected quantity. Our team will respond with pricing and available documents.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

Contact Ventro

Choose a channel to contact the Ventro team directly.

Use another email app

Opening an inquiry creates a draft, not a sent message. Review and press Send in Gmail, WhatsApp or your email app. Opening a channel passes the draft to the chosen provider. Privacy & cookies

WhatsApp